SCHEMBL19682140

SCHEMBL19682140

CC(C)(C)Cc1cc2ccccn2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
MAPT P10636 3/20 0.40
NPC1 O15118 2/20 0.40
POLB P06746 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SSTR4 P31391 1/20 0.39
ALOX15 P16050 1/20 0.39
METTL3 Q86U44 1/20 0.37
METTL14 Q9HCE5 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ESR1 P03372 1/20 0.34
HRH3 Q9Y5N1 4/20 0.32
GRN P28799 1/20 0.31
SORT1 Q99523 1/20 0.31
SLC6A2 P23975 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22401897 0.80 ALOX15 (0.40) ALOX15ESR1CHRNA7
SCHEMBL2940146 0.79 MAPT (0.43) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL2945627 0.76 NPC1 (0.41) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL2691734 0.76 NPC1 (0.43) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL2760780 0.76 NPC1 (0.43) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL24358125 0.75 NPC1 (0.40) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL28195327 0.75 METTL3 (0.42) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL16739537 0.73 METTL3 (0.35) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL30401092 0.73 TAAR1 (0.43) ALDH1A1MAPTNPC1POLBRAB9A
SCHEMBL17372780 0.73 SMN1; SMN2 (0.41) ALDH1A1MAPTNPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-10301280-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2019-05-28 US disclosed
US-20170349572-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301280-B2 Compounds and methods for kinase modulation, and indications therefor KIT, PRKCH, PRKACA ALDH1A1 2054/4885MAPT 3720/4885NPC1 2755/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP ALDH1A1 312/4885MAPT 2516/4885NPC1 868/4885
US-20170349572-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR KIT, PRKCH, PRKACA ALDH1A1 2054/4885MAPT 3720/4885NPC1 2755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.